Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms

MC Rodriguez-Oroz, M Jahanshahi, P Krack… - The Lancet …, 2009 - thelancet.com
A dopaminergic deficiency in patients with Parkinson's disease (PD) causes abnormalities of
movement, behaviour, learning, and emotions. The main motor features (ie, tremor, rigidity …

Non-motor symptoms of Parkinson's disease: diagnosis and management

KR Chaudhuri, DG Healy, AHV Schapira - The Lancet Neurology, 2006 - thelancet.com
The clinical diagnosis of Parkinson's disease rests on the identification of the characteristics
related to dopamine deficiency that are a consequence of degeneration of the substantia …

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

KR Chaudhuri, AHV Schapira - The Lancet Neurology, 2009 - thelancet.com
Several studies, including work from the Parkinson's disease (PD) non-motor group and
others, have established that the non-motor symptoms of PD are common, occur across all …

Parkinson's disease: pathophysiology.

Y Agid - The Lancet, 1991 - elibrary.ru
Reviews current information on Parkinson's disease. Brain lesions; Lesions and symptoms;
Rate of degeneration of dopaminergic neurons; Death of dopaminergic neurons; Genetic …

Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease

AA Kehagia, RA Barker, TW Robbins - The Lancet Neurology, 2010 - thelancet.com
Cognitive impairment in patients with Parkinson's disease is gaining increased clinical
significance owing to the relative success of therapeutic approaches to the motor symptoms …

The diagnosis of Parkinson's disease

E Tolosa, G Wenning, W Poewe - The Lancet Neurology, 2006 - thelancet.com
The correct diagnosis of Parkinson's disease is important for prognostic and therapeutic
reasons and is essential for clinical research. Investigations of the diagnostic accuracy for …

Parkinson's disease

LV Kalia, AE Lang - The Lancet, 2015 - thelancet.com
Parkinson's disease is a neurological disorder with evolving layers of complexity. It has long
been characterised by the classical motor features of parkinsonism associated with Lewy …

Progression of Parkinson's disease in the clinical phase: potential markers

W Maetzler, I Liepelt, D Berg - The Lancet Neurology, 2009 - thelancet.com
Neuromodulatory or even neuroprotective therapy could soon be available for Parkinson's
disease (PD), raising the question of how we should define and measure disease …

Parkinson's disease

A Samii, JG Nutt, BR Ransom - The Lancet, 2004 - thelancet.com
Parkinson's disease is the most common serious movement disorder in the world, affecting
about 1% of adults older than 60 years. The disease is attributed to selective loss of neurons …

The mystery of motor asymmetry in Parkinson's disease

R Djaldetti, I Ziv, E Melamed - The Lancet Neurology, 2006 - thelancet.com
The motor symptoms of Parkinson's disease are predominantly due to progressive
degeneration of nigral dopaminergic neurons. In most cases there is a substantial …